There are no products listed under this category.
KIT
KIT (CD117, SCFR, C-Kit) is a cell-surface receptor tyrosine kinase for the cytokine KITLG/SCF. It regulates cell survival and proliferation, haematopoiesis, stem cell maintenance, gametogenesis, mast cell development and melanogenesis. Browse Assay Genie's current range of KIT research reagents below, or read on for the biology behind the target.
KIT is a tyrosine-protein kinase that acts as the cell-surface receptor for the cytokine KITLG, also called stem cell factor (SCF). On ligand binding it activates several signalling pathways. It phosphorylates PIK3R1, PLCG1, SH2B2/APS and CBL, and activation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, drives the AKT1 pathway. Activated KIT also signals through GRB2 and RAS, RAF1 and the MAP kinases ERK1 and ERK2, and promotes activation of STAT1, STAT3, STAT5A and STAT5B. Phosphorylation of PLCG1 leads to production of diacylglycerol and inositol 1,4,5-trisphosphate. Signalling is modulated by protein phosphatases and by rapid internalisation and degradation of the receptor.
The canonical KIT protein is a glycosylated transmembrane protein with an N-terminal extracellular region of five immunoglobulin-like domains, a transmembrane region and a C-terminal intracellular tyrosine kinase domain. It can exist as a membrane-bound or soluble protein, and multiple transcript variants encoding different isoforms have been described. UniProt places it in the protein kinase superfamily, within the CSF-1/PDGF receptor subfamily; HGNC groups the KIT gene with CSF1R and FLT3 in a receptor tyrosine kinase family, and lists it among CD molecules. The mouse ortholog is Kit.
The gene was first identified as a homologue of the feline sarcoma viral oncogene v-kit, hence the name proto-oncogene c-Kit and the earlier HGNC name v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog. The alias PBT derives from the previous name piebald trait. Mutations in KIT are associated with gastrointestinal stromal tumours, mast cell disease, acute myelogenous leukaemia and piebaldism, which makes it a frequent subject in cancer and developmental biology.
KIT signalling underpins haematopoiesis and stem cell maintenance, so it is a core receptor for studying how SCF shapes progenitor survival and proliferation.
KIT has an essential role in mast cell development, migration and function, and its mutations are associated with mast cell disease.
Mutations in KIT are linked to gastrointestinal stromal tumours and acute myelogenous leukaemia, making it a focus for oncogenic kinase signalling research.
KIT regulates melanogenesis and gametogenesis, and mutations are associated with piebaldism, linking it to pigmentation and germ cell studies.
KIT is a receptor tyrosine kinase that binds KITLG/SCF at the cell surface. It then phosphorylates proteins such as PIK3R1, PLCG1 and CBL, activating AKT, RAS-MAPK and STAT pathways. These signals regulate cell survival, proliferation, haematopoiesis, mast cell function and melanogenesis.
KIT is also called CD117, SCFR, C-Kit and PBT, and its full UniProt name is Mast/stem cell growth factor receptor Kit. Earlier names include piebald trait and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog. Several transcript variants encode different isoforms, and the protein can be membrane-bound or soluble.
Yes. According to NCBI Gene, mutations in KIT are associated with gastrointestinal stromal tumours, mast cell disease, acute myelogenous leukaemia and piebaldism. The mouse counterpart is Kit. Check the datasheet of any product for its validated reactivity.
Other CSF-1/PDGF family receptors, KIT ligand and downstream signalling proteins relevant to KIT research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P10721; product specifications from Assay Genie datasheets.
There are no products listed under this category.